FAQ – Strattice™ Reconstructive Tissue Matrix (TM)
On this page you will find answers to frequently asked questions asked by our patients considering breast revision surgery using Strattice™ Reconstructive Tissue Matrix (TM). If you have a question that is not answered here, please feel free to call our office.
What should I look for when choosing a breast revision surgeon?
There are many factors to consider when choosing a surgeon to perform breast implant revision surgery. These cases are often the most challenging of all in aesthetic surgery and can be far more complex and difficult compared to the initial procedure. In certain patients, the revision procedure is further complicated by weak breast tissue. You must do your homework and choose a surgeon with a lot of experience and someone who can “think outside the box” to address these challenges. Dr. Reid and Dr. Gordon are leaders in the field of revisionary surgery.
Where can I get the latest information about Strattice™ TM?
Visit the Strattice™ LifeCell website for updates, events and announcements about the product.
How soon can I have breast augmentation implant revision surgery?
This will depend on several factors. Some women may have concerns as soon as several months after the surgery while other issues may take up to several years to manifest. If you are not satisfied with your result, the decision and timing around revision surgery will depend on your surgeon’s recommendation.
What benefits can Strattice™ TM provide for breast implant revision surgery patients?
By reinforcing weak or inadequate tissue, Strattice™ may provide the following benefits:
- Help your surgeon control the position of your breast implant pocket
- Help your surgeon support and position your breasts and breast implants in the desired location
- Allow your surgeon to redefine your breast folds and fold locations by supporting the fold repair inferiorly, laterally or medially
- Reinforce thin tissue in the presence of wrinkles and ripples on the skin surface
What types of breast implant revision surgery can Strattice™ TM be used for?
Strattice™ TM is currently used to help address a variety of challenges encountered in mastopexy augmentation and revisionary procedures due to weak or inadequate tissue, such as bottoming out, implant malposition, symmastia, wrinkling and rippling, poor skin quality and capsular contracture.
Why might Strattice™ TM be recommended for my breast implant revision surgery?
Through advanced surgical techniques, Strattice™ TM may help achieve the desired surgical outcome and may decrease the chance of some complications and additional revision procedures in the future.
How long has Strattice™ TM been available?
Strattice™ TM was introduced in the United States in February 2008. The supplier of Strattice™ TM, LifeCell™, also supplies AlloDerm® Regenerative Tissue Matrix, a product which has been used breast cancer reconstruction since 2002.
What is Strattice™ TM?
Strattice™ TM is an acellular tissue matrix or ADM designed to reinforce weak tissue and support tissue regeneration through rapid revascularization, cell repopulation, and white cell migration. It is derived from porcine dermis and is a strong, pliable, sterile product. Porcine products have been widely used for the repair and replacement of damaged tissues such as heart valves. Strattice™ TM is recommended for use in soft-tissue repair where weakness or damaged tissue exists, including breast implant revision procedures where existing tissue is inadequate or thin.
